Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Groups A, C, Y and W-135)

Meningococcal polysaccharide diphtheria toxoid conjugate vaccine · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Groups A, C, Y and W-135), covering 2018-01-08 to 2018-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam [Phase 2]

See pricing